HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ria Gupta Selected Research

purmorphamine

3/2022Smo-Shh Agonist Purmorphamine Prevents Neurobehavioral and Neurochemical Defects in 8-OH-DPAT-Induced Experimental Model of Obsessive-Compulsive Disorder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ria Gupta Research Topics

Disease

1Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
04/2022
1Neoplasms (Cancer)
04/2022
1Bacterial Infections (Bacterial Infection)
04/2022
1Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive)
03/2022
1Inflammation (Inflammations)
03/2022
1Demyelinating Diseases (Demyelinating Disease)
01/2021
1Multiple Sclerosis
01/2021

Drug/Important Bio-Agent (IBA)

1Anti-Bacterial Agents (Antibiotics)IBA
04/2022
1OPC-67683IBA
04/2022
1NitroimidazolesIBA
04/2022
1pretomanidIBA
04/2022
1Neurotransmitter Agents (Neurotransmitter)IBA
03/2022
1Neuroprotective AgentsIBA
03/2022
1purmorphamineIBA
03/2022
18-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)IBA
03/2022
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2021
1Ethidium (Ethidium Bromide)IBA
01/2021
1pregna-4,17-diene-3,16-dione (guggulsterone)IBA
01/2021